Corrective Actions Lead Beijing FDA To Lift Drug Ad Suspensions, But SFDA Uncovers More Infractions
This article was originally published in PharmAsia News
SHANGHAI - China's State Food and Drug Administration Nov. 7 issued a report summarizing illegal pharmaceutical and medical device advertisements uncovered by China's local FDAs, and announced that advertising licenses for nine drugs and seven medical devices would be suspended for one year because of incorrect or exaggerated content
You may also be interested in...
SHANGHAI - China's State Administration of Traditional Chinese Medicine instituted the country's first national TCM medical advertisement inquiry system on Aug. 1 in an attempt to check frivolous advertising of TCM services
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).